1. Home
  2. CLNE vs CMPX Comparison

CLNE vs CMPX Comparison

Compare CLNE & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Fuels Corp.

CLNE

Clean Energy Fuels Corp.

HOLD

Current Price

$1.58

Market Cap

447.1M

Sector

Utilities

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.16

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLNE
CMPX
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.1M
408.8M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
CLNE
CMPX
Price
$1.58
$2.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$3.32
$14.57
AVG Volume (30 Days)
1.5M
2.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$341,599,000.00
N/A
Revenue This Year
$1.13
N/A
Revenue Next Year
$22.65
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$1.61
52 Week High
$3.11
$6.88

Technical Indicators

Market Signals
Indicator
CLNE
CMPX
Relative Strength Index (RSI) 36.45 45.27
Support Level $1.66 $1.88
Resistance Level $2.38 $2.02
Average True Range (ATR) 0.09 0.11
MACD -0.03 -0.01
Stochastic Oscillator 9.09 37.33

Price Performance

Historical Comparison
CLNE
CMPX

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: